InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (8 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
8
T+90 hit rate
0%
T+90 mean return
-37.4%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by ROSEN TERRY J, Chairman & CEO. Officer active across 1 company, notably Arcus Biosciences, Inc.. Cumulatively, 18 reports have been logged. Breakdown: 1 buy · 8 sells. Total volume traded: €960k. Activity tracked since 16 June 2021. The latest transaction was disclosed on 27 February 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations18 total
19,800 shares@ US$10.1759.1% of flowCommon StockSEC:0001724521-25-000045:0
Canonical exit: 28 May 2025 (T+90)
165,000 shares0Common StockSEC:0001724521-25-000020:0
37,882 shares@ US$16.0827.4% of flowCommon StockSEC:0001724521-24-000182:0
12,670 shares@ US$16.979.4% of flowCommon StockSEC:0001724521-24-000129:0
100,000 shares0Common StockSEC:0001724521-24-000026:0
448 shares0Common StockSEC:0001724521-24-000003:0
13,705 shares@ US$17.7410.5% of flowCommon StockSEC:0001724521-23-000064:0
8,762 shares@ US$19.357.3% of flowCommon StockSEC:0001209191-23-038152:0
105,700 shares0Common StockSEC:0001209191-23-004870:0
10,983 shares@ US$30.6614.9% of flowCommon StockSEC:0001209191-22-061758:0
1,361 shares@ US$21.711.3% of flowCommon StockSEC:0001209191-22-038396:1
3,252 shares@ US$22.293.2% of flowCommon StockSEC:0001209191-22-038396:2
4,241 shares@ US$20.720.0028% mcap23.5% of flowCommon StockSEC:0001209191-22-038396:0
321,074 shares0Common StockSEC:0001209191-22-017967:0
1,680 shares@ US$39.59162.8% of flowCommon StockSEC:0001209191-21-070557
1,680 shares@ US$39.59160.0020% mcap16.6% of flowCommon StockSEC:0001209191-21-070557:0
3,809 shares@ US$24.133.6% of flowCommon StockSEC:0001209191-21-042080
3,809 shares@ US$24.130.0026% mcap21.6% of flowCommon StockSEC:0001209191-21-042080:0
18 of 18 declarations
About ROSEN TERRY J
Terry J. Rosen is the Chief Executive Officer of Arcus Biosciences, Inc. He is responsible for the strategic and operational direction of the company. His expertise in the biopharmaceutical sector is an asset for developing innovative products.
